Veeva Systems Inc.

Valuation Analysis

About the Company

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel e

Veeva Systems Inc. Stock at a Glance

Veeva Systems Inc. (VEEV) is currently trading at $159.54 with a market capitalization of $25.9B. The trailing P/E ratio stands at 28.24x, with a forward P/E of 15.9x. The 52-week range spans from $148.05 to $310.50; the current price is 48.6% below the yearly high. Year-over-year revenue growth stands at +16.3%. The net profit margin stands at 28.37%.

💰 Dividend

Veeva Systems Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

27 analysts rate Veeva Systems Inc. (VEEV) on consensus: Buy. The average price target is $245.48, implying +53.87% from the current price. Analyst price targets range from $165.00 to $350.00.

Veeva Systems Inc.: The Investment Case in Detail

Veeva Systems Inc. (VEEV) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 16.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 75.02%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Free cash flow is positive and net margins stand at 28.37%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

Valuation in Context

With a PEG ratio of 0.72, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

What to Watch Next

• The forward P/E of 15.9x is meaningfully below the trailing 28.24x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 53.87% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (5.9%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Veeva Systems Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.